Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -11.16 is 100% above its 5-year average of -2758.31, near the high end of its 5-year range (-4948.02–-7.47).
97.25% above its 12-month average of -405.74.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.12.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 24 comparable quarters.
EARNINGS PER SHARE (EPS)
-11.16
EARNINGS PER SHARE (EPS) AVG TTM
-405.74
EARNINGS PER SHARE (EPS) AVG 3Y
-2510.68
EARNINGS PER SHARE (EPS) AVG 5Y
-2758.31
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+97.25%
CURRENT VS 3Y AVG
+99.56%
CURRENT VS 5Y AVG
+99.60%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
PRF Technologies Ltd.
Market Cap
$72318.00
Earnings Per Share (EPS)
-11.16
TTM Avg
-405.74
3Y Avg
-2510.68
5Y Avg
-2758.31
Market Cap
$62143.00
Earnings Per Share (EPS)
N/A
TTM Avg
-459.91
3Y Avg
-720819.96
5Y Avg
-483554.38
Market Cap
$95424.00
Earnings Per Share (EPS)
N/A
TTM Avg
-5.39
3Y Avg
-4.78
5Y Avg
-3.78
Market Cap
$108729.00
Earnings Per Share (EPS)
-56.54
TTM Avg
-2021.61
3Y Avg
-2656.46
5Y Avg
-1785.38
Market Cap
$30755.00
Earnings Per Share (EPS)
N/A
TTM Avg
-110.58
3Y Avg
-60.80
5Y Avg
-49.51
Market Cap
$6159.00
Earnings Per Share (EPS)
N/A
TTM Avg
-24.78
3Y Avg
156.25
5Y Avg
124.99
Market Cap
$242924.00
Earnings Per Share (EPS)
N/A
TTM Avg
-446.18
3Y Avg
-284.47
5Y Avg
-299.57
Market Cap
$381125.00
Earnings Per Share (EPS)
N/A
TTM Avg
-48.50
3Y Avg
-108.50
5Y Avg
-157.67
Market Cap
$483178.00
Earnings Per Share (EPS)
-2.74
TTM Avg
-4.14
3Y Avg
-35.99
5Y Avg
-26.33
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PRF Technologies Ltd. (PRFX) | $72318.00 | -11.16 | -405.74 | -2510.68 | -2758.31 |
| Akanda Corp. (AKAN)vs › | $62143.00 | N/A | -459.91 | -720819.96 | -483554.38 |
| Psyence Biomedical Ltd. (PBM)vs › | $95424.00 | N/A | -5.39 | -4.78 | -3.78 |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108729.00 | -56.54 | -2021.61 | -2656.46 | -1785.38 |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30755.00 | N/A | -110.58 | -60.80 | -49.51 |
| NewGenIvf Group Limited (NIVF)vs › | $6159.00 | N/A | -24.78 | 156.25 | 124.99 |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | N/A | -446.18 | -284.47 | -299.57 |
| Niki BioSolutions, Inc. (NIKI)vs › | $381125.00 | N/A | -48.50 | -108.50 | -157.67 |
| XORTX Therapeutics Inc. (XRTX)vs › | $483178.00 | -2.74 | -4.14 | -35.99 | -26.33 |
| HCW Biologics Inc. (HCWB)vs › | $559702.00 | -54.17 | -34.20 | -18.78 | -13.04 |
Trailing EPS (TTM)
$-11.16
Forward EPS (Est.)
$-176.40
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -7.47 |
| 2024-12-31 | -804.00 |
| 2023-12-31 | -4283.23 |
| 2022-12-31 | -4948.02 |
| 2021-12-31 | -4430.82 |
| 2020-12-31 | -2076.30 |
| 2019-12-31 | -1552.86 |
| 2018-12-31 | -363.25 |
| 2017-12-31 | -916.75 |
